Tudorza Pressair (TU-door-za, aclidinium), a new inhaled anticholinergic for COPD
Reps will promote Tudorza Pressair (TU-door-za, aclidinium), a new inhaled anticholinergic for COPD.
It's an alternative to tiotropium (Spiriva) for maintenance treatment of COPD bronchospasm.
Aclidinium is a bronchodilator comparable to tiotropium.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote